tiprankstipranks
BioNano Genomics Inc (DE:2Y3)
BERLIN:2Y3

BioNano Genomics (2Y3) Stock Investors

0 Followers
Based on 672,619 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.4% of all portfolios hold DE:2Y3
On average, investors allocate 3.05% of their portfolios to DE:2Y3
The average holding size of this company in investors' portfolios.

Investor Sentiment

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 672,619 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 2Y3

0.7%
Last 7
Days
3.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:2Y3, out of 672,619 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

2Y3 Investor Activity

No data currently available
Based on the activity of 12,548 investors who made their portfolios public
The table shows changes in 2Y3 in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

2Y3 Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
6.59%
+1.02%
+2.72%
27.13B
Technology
AMC Entertainment
6.02%
-0.35%
+2.78%
7.47B
Consumer Cyclical
Moderna
5.23%
+0.41%
+0.45%
41.18B
Healthcare
ChargePoint Holdings
4.88%
-0.20%
+0.86%
2.84B
Technology
Blink Charging Co
4.17%
+0.94%
+3.03%
386.22M
Utilities
Nikola
6.16%
+2.53%
+7.89%
1.79B
Energy
Li Auto
5.73%
+0.68%
+3.76%
44.79B
Consumer Cyclical
General Electric
5.59%
+0.22%
+2.73%
123.05B
Industrials
Twilio
3.12%
+0.36%
+3.20%
11.27B
Technology
Plug Power
4.85%
-0.01%
+1.68%
6.94B
Energy
Based on the activity of 672,619 active portfolios
Open your Smart Portfolio

2Y3 Investor Analysis

DE:2Y3 investors under 35

Under 35

4.6%
Last 30 days
Holdings Change
16.6%
of DE:2Y3 holders
are under 35
Average Segment Performance
Average P/E Ratio-16.10
Beta10.87
Dividend Yield4.43%
DE:2Y3 investors between 35–55

Between 35–55

7.7%
Last 30 days
Holdings Change
62.0%
of DE:2Y3 holders
are between 35–55
Average Segment Performance
Average P/E Ratio-7.04
Beta14.57
Dividend Yield4.62%
DE:2Y3 investors over 55

Over 55

12.1%
Last 30 days
Holdings Change
21.4%
of DE:2Y3 holders
are over 55
Average Segment Performance
Average P/E Ratio-3.14
Beta5.30
Dividend Yield4.61%
Overview of age group and performance of DE:2Y3 stock investors
See who invests in 2Y3 according to age group and performance.

FAQ

How many retail Investors hold DE:2Y3?
0.4% of TipRanks' retail investors hold DE:2Y3 in their portfolios.
    What is DE:2Y3 Investor Sentiment?
    DE:2Y3’s Investor Sentiment is Positive.
      What percentage of retail investors changed their holding of DE:2Y3 in the last 7 days?
      ▲ 0.7% of TipRanks' retail investors changed their holding of DE:2Y3 in the last 7 days.
        What percentage of retail investors changed their holding of DE:2Y3 in the last 30 days?
        ▲ 3.0% of TipRanks' retail investors changed their holding of DE:2Y3 in the last 30 days.
          What is the average age of retail investors who hold DE:2Y3?
          The average age of DE:2Y3 Holders is between 35–55.
            What other stocks have DE:2Y3 investors also bought?
            DE:2Y3 Investors also bought DKNG, AMC, MRNA, CHPT, BLNK, NKLA, LI, GE, TWLO, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AMRNAmarin
              ARWRArrowhead Pharmaceuticals
              AZNAstraZeneca
              BDXBecton Dickinson
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis